Teachers Retirement System of The State of Kentucky Has $4.25 Million Holdings in Encompass Health Corporation (NYSE:EHC)

Teachers Retirement System of The State of Kentucky boosted its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 9.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 41,927 shares of the company's stock after acquiring an additional 3,602 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Encompass Health were worth $4,246,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of EHC. HighTower Advisors LLC boosted its position in Encompass Health by 10.3% during the 4th quarter. HighTower Advisors LLC now owns 18,955 shares of the company's stock worth $1,751,000 after acquiring an additional 1,764 shares during the period. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Encompass Health by 8.2% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 9,488 shares of the company's stock valued at $876,000 after buying an additional 716 shares during the last quarter. Signaturefd LLC lifted its holdings in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after buying an additional 125 shares during the last quarter. Xponance Inc. lifted its holdings in shares of Encompass Health by 6.0% during the 4th quarter. Xponance Inc. now owns 11,417 shares of the company's stock valued at $1,054,000 after buying an additional 651 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of Encompass Health during the 4th quarter valued at about $403,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider directly owned 11,958 shares in the company, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Mark J. Tarr sold 118,384 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the sale, the chief executive officer owned 527,070 shares in the company, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 132,663 shares of company stock worth $16,034,082. Company insiders own 2.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Barclays lifted their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Royal Bank Of Canada lifted their price target on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Finally, UBS Group boosted their target price on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Seven investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Encompass Health currently has a consensus rating of "Buy" and a consensus target price of $131.50.

Encompass Health Stock Up 0.0%

Shares of EHC stock opened at $110.04 on Tuesday. Encompass Health Corporation has a 12 month low of $82.74 and a 12 month high of $123.13. The firm has a market cap of $11.09 billion, a PE ratio of 22.74, a price-to-earnings-growth ratio of 2.23 and a beta of 0.88. The stock has a 50 day moving average of $119.05 and a 200-day moving average of $107.02. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the company earned $1.12 earnings per share. The company's quarterly revenue was up 10.6% compared to the same quarter last year. On average, equities analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st were issued a dividend of $0.17 per share. The ex-dividend date was Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.62%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.